Effect of aerobic exercise training on inflammatory markers and sex hormones in asthmatic women

Effect of 12 weeks of aerobic exercise training on sex hormones and blood markers of airway inflammation in mid luteal phase of asthmatics women

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016052328028N1

Enrollment

Registered

2017-01-05

Start date

2016-02-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma. Asthma

Interventions

Intervention 1: Intervention : participating in aerobic training in 12 weeks, 3 times a week, 60 minutes each session. Intervention 2: Control: no intervention for control group.

Lifestyle

Intervention : participating in aerobic training in 12 weeks, 3 times a week, 60 minutes each session.

Control: no intervention for control group.

Eligibility

Sex/Gender

Female

Age

25 Years to 42 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: mild to moderate asthma; inactive; regular menstrual cycle and Exclusion criteria: menstrual disorders; smoking; cardiovascular diseases; other pulmonary diseases

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Eosinophil%. Timepoint: At baseline and after 3 month exercise training. Method of measurement: Blood collection, CBC-PBS.;IgE. Timepoint: at baseline and after 3 month exercise training. Method of measurement: Blood collection, immunoassay system (Siemens,USA).;IL-4,IL-5,IL-13. Timepoint: At baseline and after 3 month exercise training. Method of measurement: Blood collection, sandwich ELISA kits (R&D, Minneapolis, MN).;Estrogen. Timepoint: At baseline and after 12 weeks exercise training. Method of measurement: Blood collection, Inestrument Chemiluminescense Liaison(Diasorin)-Germany.;Progesterone. Timepoint: At baseline and after tree mounth exercise training. Method of measurement: Blood collection, Chemiluminescence Liaison(Diasorin)-Germany.	—

Measure

Time frame

Eosinophil%. Timepoint: At baseline and after 3 month exercise training. Method of measurement: Blood collection, CBC-PBS.;IgE. Timepoint: at baseline and after 3 month exercise training. Method of measurement: Blood collection, immunoassay system (Siemens,USA).;IL-4,IL-5,IL-13. Timepoint: At baseline and after 3 month exercise training. Method of measurement: Blood collection, sandwich ELISA kits (R&D, Minneapolis, MN).;Estrogen. Timepoint: At baseline and after 12 weeks exercise training. Method of measurement: Blood collection, Inestrument Chemiluminescense Liaison(Diasorin)-Germany.;Progesterone. Timepoint: At baseline and after tree mounth exercise training. Method of measurement: Blood collection, Chemiluminescence Liaison(Diasorin)-Germany.

—

Secondary

Measure	Time frame
Body Mass Index(BMI). Timepoint: At baseline and after 3 month exercise training. Method of measurement: Omron Body Composition Monitor, Germany.;Forced expiratory volume in 1 second. Timepoint: At baseline and after 3 month exercise training. Method of measurement: Spirometer model ST-95 Fukuda. Sanjio. Spiroanalayzer, Japan.;Vo2peak. Timepoint: At baseline and after 3 month exercise training. Method of measurement: Modified Astrand Treadmill test.	—

Measure

Time frame

Body Mass Index(BMI). Timepoint: At baseline and after 3 month exercise training. Method of measurement: Omron Body Composition Monitor, Germany.;Forced expiratory volume in 1 second. Timepoint: At baseline and after 3 month exercise training. Method of measurement: Spirometer model ST-95 Fukuda. Sanjio. Spiroanalayzer, Japan.;Vo2peak. Timepoint: At baseline and after 3 month exercise training. Method of measurement: Modified Astrand Treadmill test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAzam Zarneshan

Azerbaijan Shahid Madani University

zarneshan@azaruniv.ac.ir, baraziliya@gmail.com+98 41 3432 7526

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026